Recombinant Human BRAK (CXCL14)

Détails du Produit

Catalog Number: 300-50

Description:

Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 α and β. Recombinant Human BRAK is a 9.4 kDa protein containing 77 amino acid residues.

Source: E.coli

Synonyms: Breast and Kidney-expressed chemokine, CXCL14, bolekine, NJAC

AA Sequence: SKCKCSRKGP KIRYSDVKKL EMKPKYPHCE EKMVIITTKS VSRYRGQEHC LHPKLQSTKR FIKWYNAWNE KRRVYEE

Purity: ≥ 98% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Determined by its ability to chemoattract activated monocytes using a concentration range of 1.0-10.0 ng/ml.

Cross Reactivity:

Bacteria, Human , Mouse

Research Interest

Country Of Origin: USA

Not for human use.

Products Cited

Cross-Reactivity

Applications

300-28B, 300-45, 300-47, 300-50, 300-57,

Human

in vitro

Products Cited

Cross-Reactivity

Applications

300-50,

Mouse

in vitro

Products Cited

Cross-Reactivity

Applications

300-11, 300-12, 300-14, 300-16, 300-20, 300-26, 300-29A, 300-31, 300-39, 300-40, 300-41, 300-46, 300-55, 300-57, 200-08M, 300-06, 300-22, 300-28A, 300-47, 300-50,

Bacteria

in vitro

Products Cited

Cross-Reactivity

Applications

300-50,

Mouse

in vivo

Products Cited

Cross-Reactivity

Applications

250-06, 300-11, 300-12, 300-14, 300-16, 300-20, 300-21, 300-26, 300-29A, 300-29B, 300-30, 300-31, 300-33, 300-34, 300-36, 300-38, 300-39, 300-40, 300-41, 300-43, 300-44, 300-46, 300-48, 300-55, 300-57, 200-08M, 250-04, 250-12, 250-37, 300-04, 300-06, 300-08, 300-09, 300-15, 300-17, 300-22, 300-24, 300-28A, 300-29, 300-35, 300-37, 300-45, 300-47, 300-50, 300-54, 300-56,

Bacteria

in vitro

Products Cited

Cross-Reactivity

Applications

450-16, 300-50,

Bacteria

in vitro

Products Cited

Cross-Reactivity

Applications

300-50,

Human

in vitro

Products Cited

Cross-Reactivity

Applications

250-01, 250-04, 250-06, 250-07, 250-10, 250-11, 250-12, 250-13, 250-15, 250-16, 250-17, 250-18, 250-20A, 250-20B, 250-22, 250-23, 250-24, 250-26, 250-27, 250-27B, 250-28, 250-29, 250-30, 250-32, 250-36, 250-37, 250-39,

Mouse

Binding Assay

300-34, 300-11, 300-15, 300-29B, 300-46, 300-48, 300-54, 300-08, 300-28A, 300-43, 300-45, 300-31, 300-36A, 300-14, 300-39, 300-55, 300-16, 300-28B, 300-22, 300-44, 300-33, 300-26, 300-38, 300-57, 300-24, 300-40, 300-41, 300-30, 300-12, 300-50, 300-47, 300-29A, 300-35, 300-17, 300-09, 300-56, 300-04, 300-21,

Human

in vitro

Products Cited

Cross-Reactivity

Applications

300-21, 300-28A, 300-47, 300-50,

Human

in vitro

Products Cited

Cross-Reactivity

Applications

300-37, 300-04, 300-08, 300-56, 300-09, 300-58, 300-06, 300-17, 300-15, 300-21, 300-24, 300-38, 300-43, 300-44, 300-30, 300-34, 300-29B, 300-29A, 300-35, 300-36A, 300-29, 300-33, 300-48, 300-54, 300-11, 300-39, 300-40, 300-16, 300-22, 300-22B, 300-41, 300-14, 200-08, 300-26, 300-12, 300-46, 300-28A, 300-28B, 300-47, 300-50, 300-55, 300-31,

Human

Chemotaxis Assay

Products Cited

Cross-Reactivity

Applications

300-50, 500-P237,

Mouse

Immunostaining

Chémokines